These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3536238)

  • 1. Biology of acute myeloid leukaemia.
    Messner HA; Griffin JD
    Clin Haematol; 1986 Aug; 15(3):641-67. PubMed ID: 3536238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of flow cytometric analyses of blast cells in assessing the phenotype of the leukemia colony-forming cell (L-CFC) population in acute myeloid leukemia.
    Howell AL; Stukel TA; Bloomfield CD; Ball ED
    Bone Marrow Transplant; 1992 Sep; 10(3):261-6. PubMed ID: 1422480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The blast cells of acute myeloblastic leukaemia.
    McCulloch EA
    Clin Haematol; 1984 Jun; 13(2):503-15. PubMed ID: 6380855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation time of leukaemic blast progenitor cells.
    Minden M; Major P; Griffin J; Wu A; Kufe D
    Cell Tissue Kinet; 1983 Nov; 16(6):577-82. PubMed ID: 6578875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The determination of myeloid-committed stem cells in systemic disorders of myelopoiesis: implications for physiopathology, diagnosis and prognosis].
    Hinterberger W
    Acta Med Austriaca Suppl; 1981; 21():1-20. PubMed ID: 6949436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity of 4-hydroperoxycyclophosphamide for the blast progenitors of acute myeloblastic leukemia.
    Nara N; Suzuki T; Yamashita Y; Murohashi I; Aoki N
    Cancer Res; 1988 May; 48(9):2348-52. PubMed ID: 3162711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lineage heterogeneity in acute leukaemia: acute mixed-lineage leukaemia and lineage switch.
    Stass SA; Mirro J
    Clin Haematol; 1986 Aug; 15(3):811-27. PubMed ID: 3536242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term marrow culture of cells from patients with acute myelogenous leukemia. Selection in favor of normal phenotypes in some but not all cases.
    Coulombel L; Eaves C; Kalousek D; Gupta C; Eaves A
    J Clin Invest; 1985 Mar; 75(3):961-9. PubMed ID: 3856572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trophoblast cell line conditioned medium for in vitro culture and antigenic characterization of acute myeloid leukemia clonogenic cells.
    Ferrero D; Pregno P; Tarella C; Ruscetti FW; Pileri A; Gallo E
    Cancer Res; 1987 Dec; 47(23):6413-7. PubMed ID: 3499973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotyping of acute myeloid leukemia cells.
    Ball ED
    Clin Lab Med; 1990 Dec; 10(4):721-36. PubMed ID: 2272171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
    Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
    Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective in vitro growth of primitive hematopoietic cells from pediatric patients with acute myeloid leukemia.
    Dorantes-Acosta E; Chávez-González A; Santos JI; Medina-Sanson A; Mayani H
    Pediatr Blood Cancer; 2008 Dec; 51(6):741-6. PubMed ID: 18680148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proliferation and differentiation of leukemic cells in acute myelocytic leukemia].
    Nara N
    Rinsho Byori; 1998 May; 46(5):424-9. PubMed ID: 9627492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
    Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of stem cell factor (SCF) on the in vitro growth of leukemic blast progenitors in acute non-lymphocytic leukemia.
    Nara N; Tanikawa S; Nagata K; Hamaguchi H; Tomiyama J
    Int J Hematol; 1993 Aug; 58(1-2):27-35. PubMed ID: 7693028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity in acute myeloblastic leukemia.
    McCulloch EA; Kelleher CA; Miyauchi J; Wang C; Cheng GY; Minden MD; Curtis JE
    Leukemia; 1988 Dec; 2(12 Suppl):38S-49S. PubMed ID: 3199879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia.
    Suárez L; Vidriales B; García-Laraña J; López A; Martínez R; Martín-Reina V; Tormo M; González-San Miguel JD; Lavilla E; García-Boyero R; Orfao A; San Miguel JF;
    Haematologica; 2001 Dec; 86(12):1287-95. PubMed ID: 11726321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of proliferation and differentiation of acute myeloid leukemia cells on a bone marrow stroma in culture.
    Schölzel C; Löwenberg B
    Exp Hematol; 1985 Aug; 13(7):664-9. PubMed ID: 3861327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute leukaemia: implications of recent findings in cell biology.
    Benestad HB
    Folia Biol (Praha); 1978; 24(1):1-15. PubMed ID: 273000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinations of stem cell factor with other hematopoietic growth factors enhance growth and sensitivity to cytosine arabinoside of blast progenitors in acute myelogenous leukemia.
    Inatomi Y; Toyama K; Clark SC; Shimizu K; Miyauchi J
    Cancer Res; 1994 Jan; 54(2):455-62. PubMed ID: 7506123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.